Table of Contents
Description
Priority Announcements on CIHR Operating Grant competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the "201003MOP" competition of the Operating Grant: 2009-2010 funding opportunity.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations. Should CIHR funding levels be decreased by Parliament, CIHR reserves the right to defer or suspend payments to grants received as a result of this funding opportunity.
Funds Available for Research in All Areas:
Funds are available for applications in all areas of research that address any important health problem or issue through the "201003MOP" competition of the Operating Grant: 2009-2010 funding opportunity.
Funds Available for Research in Specific Areas:
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
A. CIHR Research Priority Areas:
- Arthritis (The Arthritis Society)
- Blood Supply Risk
- Blood Utilization and Conservation
- Breast Cancer
- Ethics
- HIV/AIDS
- Huntington's (Prize)
- Neuromuscular Research
- Obesity – Prevention and Treatment
- Parkinson's Disease
- Regional Partnerships Program – Manitoba
- Regional Partnerships Program – New Brunswick
- Regional Partnerships Program – Newfoundland and Labrador
- Regional Partnerships Program – Nova Scotia
- Regional Partnerships Program – Prince Edward Island
- Regional Partnerships Program – Saskatchewan
- Reproductive and Child Health (Start Up Grants)
- Schizophrenia (Prize)
- Spinal Cord Research (Prize)
- Transfusion Related Acute Lung Injury (TRALI)
B. Research Related to CIHR Institute Mandates:
- Cancer Research (Bridge Funding)
- Circulatory and Respiratory Health (Bridge Funding)
- First Nations, Inuit and/or Métis Health
- Genetics (Bridge Funding)
- Genetics - Maud Menten New Principal Investigator Prizes (2010)
- Infection and Immunity (Bridge Funding) (Updated: 2010-01-26)
- Musculoskeletal Health, Arthritis, Skin and Oral Health
- Nutrition, Metabolism and Diabetes (Bridge Funding)
- Nutrition, Metabolism and Diabetes (Bridge Funding for Assistant Professors, Clinicians, New Investigators)
Top
Objectives
A. CIHR Research Priority Areas:
1. Arthritis (The Arthritis Society)
Summary:
- The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA), in partnership with The Arthritis Society will support a limited number of applications that are determined to be highly relevant to the research priority areas described below.
Funds Available:
- The total amount available for this initiative provided by The Arthritis Society is $ 2,400,000 over 3 years. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 120,000 per annum for up to 3 years.
Additional information:
- Complete applications must include an additional 1 page Statement of Relevance attachment in which applicants must describe why their research is relevant to arthritis and what they hope to achieve. The relevance must be clearly identifiable and justified.
- When preparing the Statement of Relevance, applicants should describe how the expected results of the proposed research will further (one or more of the following):
- the understanding of the underlying causes (etiology/mechanisms) of arthritis
- the development of effective treatments of arthritis
- the understanding of the consequences (impact/outcomes) of arthritis
- influence health or public policy to improve the quality of life for individuals living with arthritis
- The Statement of Relevance page must be mailed directly to CIHR by the deadline date, at the address listed below. CIHR will forward the Statement of Relevance to the Society.
RE: " The Arthritis Society Priority Announcement"
Targeted Initiatives Branch
ATTN: Nancy Mason MacLellan
Canadian Institutes of Health Research
160 Elgin Street, room 97
Address Locator: 4809A
Ottawa, Ontario K1A 0W9
- Grantees will also be required to provide annually to The Society the following documents at the address listed below:
- Financial accounting
- Progress report
- A list of all KT activities including publications, presentations, stakeholder engagement and other relevant KT activities (e.g., patents, copyrights) resulting in whole or in part from The Society/CIHR
Attn: Ms. Julie Wysocki
Manager, National Research and Career Development Program
1700-393 University Ave
Toronto, ON M5G 1E6
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
2. Blood Supply Risk
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Seeking applications in the following areas:
- Blood donor deferral strategies and the risk of transmission of blood borne diseases
- Policy development and social aspects of blood system safety and risk tolerance
- Emerging pathogens in specific populations including sexually active gay men
- More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their web sites.
Funds Available:
- CBS has committed up to $1.0M over three years for this initiative through CIHR peer review.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by the Canadian Blood Services.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
3. Blood Utilization and Conservation
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Blood utilization and conservation
- Seeking applications in the following areas: Blood products and their derivatives include cellular blood components (red blood cells and platelets), plasma products, therapeutic proteins fractionated from plasma, and replacement products for any of these including both recombinant proteins and synthetic materials. Conservation refers to strategies to reduce the use of donor-derived blood products.
- More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their web sites.
Funds Available:
- CBS has committed up to $1.0M over three years for this initiative through CIHR peer review.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by the Canadian Blood Services.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
4. Breast Cancer
Summary:
- The CIHR in partnership with the Canadian Breast Cancer Research Alliance (CBCRA), will fund applications that are determined to be relevant to the research priority areas described below:
- It is the objective of the Alliance to fund a broad spectrum of cancer research in Canada that will have relevance for prevention, early detection, diagnosis, treatment, rehabilitation and palliation for people impacted by breast cancer. Such research could encompass, but is not limited to, fundamental laboratory investigations, clinical trials and epidemiological, psychosocial and behavioural studies and health care research. The ultimate goal is the prevention, cure and eradication of breast cancer.
- More information on the research priorities of CBCRA can be found on its web sites.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- Applicants are not required to identify Priority Announcements and Relevant Research Area in their application since the breast cancer relevance will be determined jointly by CIHR and CBCRA, based on the title, keywords and abstract of the application.
- Since applications are adjudicated and administered by CIHR, grantees will be required to submit annual financial reports to CIHR. In addition, because these grants are also considered CBCRA grants, grantees will be required to submit, to the CBCRA office, annual progress reports (to the attention of Dr. Pascale Macgregor, Canadian Breast Cancer Research Alliance, 375 University Avenue, 6th floor, Toronto ON M5G 2J5), as well as lists of all publications resulting in whole or in part from their CBCRA/CIHR grant. These publications will be included in the CBCRA Research Portfolio. Grantees will also be invited to present their results at CBCRA's Reasons for Hope conferences.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
5. Ethics
Summary:
- The CIHR Ethics Office, in partnership with the Institute of Aboriginal Peoples' Health (CIHR-IAPH) and the Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA), will fund applications that are determined to be relevant to research in ethics related to health, health research and/or health policy:
- A systematic analysis of bioethics or ethics issues associated with health, health care, health research or health policy must be a significant focus of the proposed study. Scientific, social or legal issues, if addressed, should expand the discussion or understanding of bioethical or ethical issues.
- Consideration will be given to applications concerning ethics in health, health care, health research, or health policy in relation to:
- Research with First Nations, Inuit and/or Métis peoples to enhance active living, mobility and movement, and oral health; and addresses causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions related to bones, joints, muscles, connective tissue, skin and teeth; or
- The implementation of the CIHR Guidelines for Health Research Involving Aboriginal People.
- More information on the research priorities of CIHR-Ethics Office, CIHR-IAPH and CIHR-IMHA can be found on their web sites.
Funds Available:
- The total amount available for this initiative is $ 600,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to 3 years.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- In order to maximize the number of applications funded through this initiative, the Ethics Office may invite other CIHR branches or Institutes to consider funding relevant applications that receive a score of 3.5 or above. For this purpose, the anonymized application summary will be shared with CIHR branches or CIHR Institutes at the discretion of the CIHR Ethics Branch, according to the Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP).
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
6. HIV/AIDS
Summary:
- The CIHR Institute of Infection and Immunity (CIHR-III)-CIHR HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below. Please note, in order to be considered for funding the primary research focus of the application must be HIV/AIDS.
- Health systems, services and policy
- Resilience, vulnerability and determinants of health
- Prevention technologies and interventions
- Drug development, toxicities and resistance
- Pathogenesis
- Issues of co-infection and co-morbidity
- In particular this competition, the CIHR HIV/AIDS Research Initiative encourages applications that explore the following research gap within the priority area of pathogenesis: "Immunopathogenesis in Humans", with particular focus on:
- HIV-induced modulation of host cell gene expression;
- The mechanism(s) by which HIV infection can cause immune hyperactivation; and
- Acquiring a better understanding of the pathogenic mechanisms of B-cell abnormalities in HIV disease.
- Applicants must select only ONE HIV/AIDS research priority area. If applicable, applicants are permitted to apply to additional (non-HIV/AIDS) Priority Announcements associated with this Operating Grant competition as defined in the Eligibility section of the funding opportunity.
- All applications determined to be relevant to the HIV/AIDS Research Initiative priority areas listed above will be eligible for Bridge Funding.
- Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic, is encouraged.
- More information on the research priorities of the CIHR HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website.
Funds Available:
- The total amount available for this initiative is $ 2,000,000.
- The maximum amount awarded for a single grant is $ 150,000 per annum for up to three years.
- Of the total funds available, $1,800,000 will support three-year grants:
- $ 900,000 is available to fund applications relevant to the Biomedical/Clinical Research funding stream;
- $ 900,000 is available to fund applications relevant to the Health Services/Population Health Research funding stream.
- In addition, $200,000 is currently available to support bridge grants:
- $ 100,000 is available to fund applications relevant to the Biomedical/Clinical Research funding stream;
- $ 100,000 is available to fund applications relevant to the Health Services/Population Health Research funding stream.
- The maximum amount awarded for a single bridge grant is $100,000 per annum for up to one year.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- Applications to the CIHR HIV/AIDS Research Initiative are sought in two distinct funding streams Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach across all four research pillars are strongly encouraged and accepted, applicants should clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
7. Huntington's (Prize)
Summary
- CIHR in partnership with the Huntington Society of Canada (HSC) and the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below.
- Basic biomedical research on Huntington's Disease.
- More information on the Huntington Society of Canada and CIHR-INMHA can be found on their websites.
Funds Available
- The total amount available for this initiative is $15,000.
- The maximum amount awarded for a single prize is up to $15,000 per annum for up to one year. CIHR anticipates that one prize will be funded through this competition.
- Funding from HSC will be in the form of a top-up to an operating grant from the September 2009 or March 2010 CIHR Open Operating Grant competitions.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form.
- See the section "Review Process and Evaluation Criteria-Relevance Review" for information about the relevance review process specific to Prizes in CIHR Research Priority Areas.
- Applications to the regular Operating Grant competitions will be entered automatically into priority announcement prize competitions. Consideration for funding through priority announcement prizes is in addition to consideration for other types of priority announcement funding.
- The grant/award must be held in Canada
- Recipient will be the top ranked researcher
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
8. Neuromuscular Research
Summary:
- Neuromuscular Research (Neuromuscular Research Partnership Program). The CIHR Institute of Genetics, the CIHR Institute of Musculoskeletal Health and Arthritis, the CIHR Institute of Neurosciences, Mental Health and Addiction in partnership with the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada will fund applications that are determined to be relevant to the research priority areas described below:
- Amyotrophic lateral sclerosis
- Spinal muscular atrophies
- Diseases of the neuromuscular junction
- Muscular Dystrophies (e.g. Duchenne, Becker)
- Inflammatory myopathies
- Myotonia
- Metabolic or endocrine diseases of the muscle
- Congenital myopathies
- Facioscapulohumeral dystrophy (FSHD)
- Other neuromuscular disorders
- The following broad categories of research are eligible for funding:
- Basic research involving muscle or nerve biology relevant to neuromuscular disease
- Focused research directed toward an understanding of neuromuscular disease
- Applied research encompassing research designed specifically to translate promising research advances from basic research and focused research into pre-clinical and clinical investigations relevant to treatment of neuromuscular disease, but not including drug trials
- More information on the research priorities of Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada can be found on their web sites.
Funds Available:
- The total amount available for this initiative is $1,649,665.
- The duration of projects can be for up to (5) years for applications rated above CIHR's funding cut-off and up to (3) three years for applications rated below CIHR's funding cut-off but above 3.7. There is no maximum for a single grant per annum. The maximum amount awarded for a single grant will be as recommended by CIHR peer review for up to 3 years. CIHR anticipates that six to twelve grants will be funded through this competition.
Additional Information: (Updated: 2010-01-20)
- This Priority Announcement will require the completion of a Relevance Form.
- Applications receiving a score of less than 3.7 in the open competition will not be considered for funding.
- For grants funded through this program, progress and end of grant reports will be shared with funding partners.
- Equipment may not be funded under this partnership. The decision will be made in alignment with the open competition decisions.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
9. Obesity – Prevention and Treatment
Summary:
- The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) will fund applications that are determined to be relevant to the research priority areas described below:
- Prevention of obesity
- Treatment of Obesity
Funds Available:
- The total amount available for this initiative is $ 100,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to 1 year.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- Nominated Principal Investigators are eligible to receive only one grant at a time through INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement
- This Priority Announcement will apply to new grant applications as well as to renewal applications.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
10. Parkinson's Disease
Summary:
- Parkinson (Parkinson Society Canada/CIHR-INMHA Research Grant). The CIHR and the Parkinson Society of Canada will fund applications that are determined to be relevant to the research priority areas described below:
- Psychosocial research in Parkinson's Disease
- The objectives of this priority announcement are to increase interest in and encourage researchers specifically in the area of psychosocial research in Parkinson's disease (PD).
- Emphasis is placed on research directed towards closing the gap in understanding and treating non-motor symptoms of Parkinson's and may involve qualitative and /or quantitative methodologies. The inclusion of the end user in some component of the research program is a requirement for consideration of the project and must be specified.
- The following psychosocial research topics have been identified as priority issues by Parkinson's Society Canada;
- Investigating the Psychological Well Being of PLWP, Partners and Families,
- Evaluating the Benefits of Standardized care,
- Assessing Medical Services
- The Economic Burden of Parkinson's.
- Areas of interest in psychosocial research include but are not limited to:
- Research in the area of concurrency of psychiatric disorders including depression and drug/alcohol abuse amongst PLWP. Research can also focus on the psychological impact of PD on the spouse and family members, as well as individuals who live alone.
- Research that identifies best practice by focusing on the diagnosis and early treatment experiences of PLWP.
- Projects that focus on methods of improving support and access to services for people living with Parkinson's disease (PLWP). Groups include but are not limited to more advanced level PD caregivers, young onset and/or newly diagnosed individuals, individuals who live in rural area.
- Projects that focus on methods for improving appropriate services for PLWP from ethnic communities incorporating accommodation of language and cultural barriers.
- Research directed to exploring the economic burden of PD on PLWP and their families. Research should include, but is not limited to, loss of income, cost of treatments, and comparison of impact on young versus older onset patients.
- More information on the research priorities of Parkinson Society of Canada can be found on their website.
Funds Available:
- The total amount available for this initiative is $100,000.
- The maximum amount awarded for a single grant is up to $50,000 per annum for two years. CIHR anticipates that one grant will be funded through this competition.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- This grant may be awarded to an individual researcher; however, submissions from teams of researchers that reflect multi-disciplinary approaches and /or inter-regional collaboration are also strongly encouraged. Applications receiving a rating of less than 3.5 will not be considered for funding.
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- The grant is non-renewable
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
11. Regional Partnerships Program - Manitoba
Summary
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- The maximum amount awarded for a single grant is $100,000 per year for up to two years except where $100,000 is not equivalent to 75% or greater of the approved annual budget of an individual grant, then 75% pro-rated budget amount will apply.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their grant to be eligible for consideration for RPP funding.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds;
- For eligibility guidelines, see the CIHR/Manitoba RPP Program Requirements.
- When applying through ResearchNet, please ensure to select "RPP-Manitoba" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
12. Regional Partnerships Program – New Brunswick
Summary
- CIHR, through the Regional Partnerships Program (RPP), in partnership with New Brunswick-RPP is interested in funding applications in all four themes of health research that contribute to the goal of building health research capacity in New Brunswick.
- More information on the research priorities of New Brunswick can be found on their website.
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- The maximum amount awarded for a single grant is $100,000 per annum for up to five years.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The grant must be held in New Brunswick and in accordance with the CIHR-RPP guidelines;
- Funding is conditional upon the availability of funds;
- For eligibility guidelines, see the New Brunswick and Canadian Institutes of Health Research Regional Partnership Program description;
- When applying through ResearchNet, please ensure to select "RPP-New Brunswick" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
13. Regional Partnerships Program – Newfoundland and Labrador
Summary
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available
- The maximum amount awarded for a single grant will normally be up to $150,000 per annum for up to three years for new grants, and one year for renewals.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is the Office of Research and Graduate Studies (see contact information below).
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The grant must be held in NL and in accordance with the CIHR-RPP guidelines;
- Funding is conditional upon the availability of funds;
- When applying through ResearchNet, please ensure to select "RPP-Newfoundland and Labrador" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
14. Regional Partnerships Program – Nova Scotia
Summary
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available
- The maximum amount awarded for a renewal grant is $70,000 for one year.
- New grants are awarded for up to three years.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note that in order to be considered for RPP funding, researchers must submit their applications electronically to NSHRF within 5 business days of the CIHR application deadline;
- Please refer to the 2009/10 Nova Scotia - CIHR RPP Requirements document for eligibility criteria, application process and funding details PDF.
- As a condition of funding, NSHRF will require that successful applicants provide them with a copy of the CIHR Scientific Officer's Notes.
- When applying through ResearchNet, please ensure to select "RPP-Nova Scotia" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15. Regional Partnerships Program – Prince Edward Island
Summary
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island-RPP is interested in funding applications that span the four themes of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect these four themes:
- Cardiovascular and respiratory health research
- Metabolism, nutrition and diabetes
- Human development and cognition
- Cancer research
- Applied health services and health promotion
- Natural products and human health
- Population health
- More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan.
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- The maximum amount awarded for a single grant is up to $100,000 per annum for up to 3 years.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the Office of Research Development a minimum of two months prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
- The grant must be held in Prince Edward Island;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds;
- For eligibility guidelines, see the PEI-CIHR RPP program description.
- When applying through ResearchNet, please ensure to select "RPP-Prince Edward Island" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
16. Regional Partnerships Program – Saskatchewan
Summary
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan-RPP is interested in funding highly rated applications in Saskatchewan.
- Operating grants from all four themes of research will be supported based upon the rankings that they received. However, half of the available funding will be awarded based upon the following listed research priority areas:
- Health needs of Aboriginal people and seniors
- Health systems and policy research, with emphasis on: health human resources and workforce planning; quality management and improvement; primary health care; mental health and addictions; innovative delivery models; and rural and remote health services
- Determinants of health status, including early childhood development and the prevention and underlying causes of chronic and lifestyle-related disease (particularly diabetes, obesity and smoking)
- Public health including infectious diseases and water and food safety
- Synchrotron-based health research
- More information on Saskatchewan's research priorities can be found in the Health Research Strategy.
Funds Available
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- The grant amount will be as recommended by CIHR; the duration will be for two years, unless a shorter period is recommended by CIHR.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form;
- Please note that researchers must have their CIHR applications vetted by the internal review
- procedures at their University or institution prior to submitting to CIHR in order for their grant to be eligible for consideration for RPP funding:
- University of Saskatchewan - 4 weeks prior to CIHR application deadline.
- University of Regina - 4 weeks prior to CIHR application deadline.
- To be considered for the Saskatchewan priority areas (see above) researchers must provide a copy of the summary page of their application and a one-page statement justifying the fit of the application with at least one priority area. Researchers will be contacted by the Office of the Associate Vice-President Research (Health) shortly after the application deadline to provide this information.
- The grant must be held in a Saskatchewan institution by a Saskatchewan researcher; for eligibility guidelines, see the Saskatchewan - CIHR RPP Policies;
- The grant is non-renewable for the first re-application following RPP funding;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds.
- When applying through ResearchNet, please ensure to select "RPP-Saskatchewan" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
17. Reproductive and Child Health (Start Up Grants)
Summary:
- The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) will fund applications that are determined to be relevant to the research priority areas described below:
- The objective of this priority announcement is to further strengthen research that relates to the Strategic Research Priorities of the CIHR-IHDCYH by increasing research capacity. It is expected that this targeted investment will lead to increased success rates for new Principal Investigators in future CIHR regular open competitions.
Funds Available
- The total amount available for this initiative is $ 200,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 for one year.
Additional Information: (Updated: 2010-01-13)
- This Priority Announcement will require the completion of a Relevance Form.
- Grants are offered only to investigators with less than six years of experience as independent investigators since their first academic appointment (i.e. after March 2004, including experience outside Canada) and who have never held a CIHR grant as a Principal Investigator (including the Sick Kids Foundation (SKF)/IHDCYH New Investigators Grants Program).
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
18. Schizophrenia (Prize)
Summary
- CIHR in partnership with the Schizophrenia Society of Canada (SSC) and the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below.
- research related to psychosocial aspects of schizophrenia or psychosis that can contribute to an improved understanding of how quality of life for people with schizophrenia or psychosis, and their families, can be improved through education, support systems, public policy or research.
- More information on the research priorities of the Schizophrenia Society of Canada and CIHR-INMHA can be found on their websites.
Funds Available
- The total amount available for this initiative is $25,000.
- The maximum amount awarded for a single prize is up to $25,000 per annum for up to one year. CIHR anticipates that one prize will be funded through this competition.
- Funding from SSC will be in the form of a top-up to an operating grant from the September 2009 or March 2010 CIHR Open Operating Grant competitions.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form.
- See the section "Review Process and Evaluation Criteria-Relevance Review" for information about the relevance review process specific to Prizes in CIHR Research Priority Areas.
- Applications to the regular Operating Grant competitions will be entered automatically into priority announcement prize competitions. Consideration for funding through priority announcement prizes is in addition to consideration for other types of priority announcement funding.
- The grant must be held in Canada
- The recipient of the grant will be the top ranked researcher in the field of schizophrenia research from the combined results of the September 2009 and March 2010 Open Operating Grant competitions.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
19. Spinal Cord Research
Summary
- The CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA), in partnership with the Barbara Turnbull Foundation for Spinal Cord Research (BTF) and NeuroScience Canada (NSC) will fund applications that are determined to be relevant to the research priority areas described below:
- Spinal cord injury protection, repair and functional recovery.
- More information on the research priorities of CIHR-INMHA, the Barbara Turnbull Foundation for Spinal Cord Research (BTF) and NeuroScience Canada (NSC) can be found on their websites.
Funds Available
- The total amount available for this initiative is $50,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is up to $50,000 per annum for one year.
Additional Information
- This Priority Announcement will not require the completion of a Relevance Form.
- The award will be in the form of a top up to an operating grant and will be known as the Barbara Turnbull Award for Spinal Cord Research. The recipient of the award will be selected as the top ranked spinal cord researcher as identified through a keyword search of the combined results of CIHR's September 2009 and March 2010 investigator-initiated open operating grant competitions
- The award is non-renewable.
- The grant must be held in Canada.
- Recipient will be the top ranked researcher.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
20. Transfusion Related Acute Lung Injury (TRALI)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Transfusion related acute lung injury (TRALI)
- Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animals models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy making, identification of factors (including genetic factors) that increase a recipient's susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI.
- More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their web sites.
Funds Available:
- CBS has committed up to $1.0M over three years for this initiative through CIHR peer review.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by Canadian Blood Services.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
B. Research Related to CIHR Institute Mandates:
21. Cancer Research (Bridge Funding)
Summary:
- The CIHR Institute of Cancer Research (CIHR-ICR), will fund applications that are determined to be relevant to the research priority areas described below:
- The objective of the CIHR Institute of Cancer Research Bridge Funding Operating Grants is to ensure the establishment or the maintenance of excellent research programs. These one-year operating grants give new principal investigators the possibility to strengthen their proposals before resubmitting them, and they afford established principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
- More information on the mandate of CIHR-ICR can be found on its web site.
Funds Available:
- The total amount available for this initiative is $ 200,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to one year.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- ICR must be identified as the primary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Research proposals must fall within ICR's mandate.
- Provided eligible candidates remain for consideration, at least one of the grants will be allocated to new investigators, who are researchers with less than four years of experience as independent investigators since their first academic appointment, and who have never held a CIHR grant as principal investigator. Any additional funding will be allocated to the next ranked new investigator first, then the next ranked established investigator.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
22. Circulatory and Respiratory Health (Bridge Funding)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health Bridging Operating Grant Program (One-Year) is designed to fund highly ranked operating grant applications relevant to CIHR-ICRH's mandate that have just missed the CIHR Operating Grants competition funding cut-off.
- These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
Funds Available:
- The total amount available for this initiative is $ 200,000. This amount may increase if additional funding partners decide to participate.
- The maximum/minimal amount awarded for a single grant is $ 100,000 per annum for up to 1 year.
- Subject to the availability of funds, a minimum of one grant will be awarded in the area of cardiovascular research and a minimum of one grant will be awarded in the area of respiratory research.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- The grant must be held in Canada
- ICRH must be identified as the primary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application (Updated: 2010-01-11)
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
23. First Nations, Inuit and/or Métis Health
Summary:
- The CIHR Institute of Aboriginal Peoples' Health (CIHR-IAPH) will fund applications that are determined to be relevant to the research priority areas described below:
- Research Related to the mandate of CIHR-IAPH.
- IAPH fosters the advancement of a national health research agenda to improve and promote the health of First Nations, Inuit and Métis peoples in Canada, through research, knowledge translation and capacity building. The Institute's pursuit of research excellence is enhanced by respect for community research priorities and Indigenous knowledge, values and cultures.
- More information on the research priorities of CIHR-IAPH can be found on their web site.
Funds Available:
- The total amount available for this initiative is $100,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ $100,000 for one year.
Additional Information:
- This Priority Announcement will require the completion of a Relevance Form.
- The CIHR Guidelines for Health Research Involving Aboriginal People came into effect as policy for CIHR-funded research on July 1st 2008. In order to obtain institutional Research Ethics Board (REB) approval, applicants must obtain a Research Agreement, signed and dated by the appropriate community authority. In situations where obtaining a formal Research Agreement is not necessary or desirable from the community's perspective, applicants should provide a letter of community approval and a short statement of justification explaining the absence of a Research Agreement. These documents are not required as part of a complete application submission, but may be of use in demonstrating the feasibility of the proposed research to the peer review committee.
- As outlined in the CIHR Grants and Awards Guide, applicants must inform themselves about any formal review processes that may exist within the community. In communities with local Aboriginal Research Ethics Boards (REB) or other formal means of local Aboriginal research review, research projects involving Aboriginal people will need to be reviewed both by the local Aboriginal Ethics Review Board, as well as the Institutional Research Ethics board.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
24. Genetics (Bridge Funding)
Summary:
- The CIHR Institute of Genetics Bridging Operating (One-Year) Grant Program is designed to fund highly ranked operating grant applications relevant to CIHR-IG's mandate that have just missed the CIHR Operating Grants competition funding cut-off. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
Specific Eligibility Requirements:
- The IG must be identified as the primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of the CIHR operating grant application.
- Research proposals must fall within the IG's mandate.
- More information on the research priorities of CIHR-IG can be found on its web site.
Funds Available:
- The total amount currently available for this competition is $300,000. This amount may increase should additional funds become available during the competition.
- The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- The grant must be held in Canada.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
25. Genetics - Maud Menten New Principal Investigator Prizes (2010)
Summary:
- The CIHR Institute of Genetics (IG) established the Maud Menten New Principal Investigator Prize to recognize and support the research excellence of Canadian New Investigators working within the IG's mandate. The research grant is awarded annually and intended to offset the direct costs of the recipient's research program.
- Dr. Menten's outstanding career as a biomedical scientist led to many achievements including important co-discoveries relating to blood sugar, haemoglobin and kidney functions. In 1913, a collaboration with Leonor Michaelis on the behaviour of enzymes resulted in the Michaelis-Menten equation, a biochemical concept so fundamental that it is familiar to first-year science students.
- More information on the research priorities of CIHR-IG can be found on the Institute's web site.
Funds Available:
- There are currently no funds available for the Winter 2010 Priority Announcements. The total amount available is dependent on the number of successful applicants from the Fall 2009 Priority Announcements.
- The CIHR Institute of Genetics Maud Menten New Investigator Prize consists of a one-year, non-renewable $30,000 research grant.
- One prize in each of the following research areas is available: i) biomedical; ii) clinical; and iii) health services/population health, including genetic ethical, legal and social issues. For each research area, the IG also makes available two finalist prizes.
- Finalist prizes consist of a one-year, non-renewable $1,000 research grant.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- All Nominated Principal Investigators who meet the following criteria will be automatically considered for the IG Maud Menten New Principal Investigator Prize (2010):
- successful in either the September 2009 or March 2010 CIHR Operating Grants competition with a rating of 4.0 or greater;
- identified the IG as their primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of their operating grant application; and
- held a full-time appointment as an independent investigator, while actively engaged in CIHR research, including research performed in non-academic setting (e.g. industry, government) for a period of less than 60 months before the competition deadline associated with their successful operating grant application (i.e. September 15 for the 2009 competition and March 1 for the 2010 competition).
- The New Principal Investigator with the highest ranked CIHR Operating Grant application - from the combined results of the September 2009 and March 2010 CIHR Operating Grant competitions - in each research area will be the recipient of one of the three prizes. For each research area, two finalist prizes are also available and will be selected in rank order.
- The grant must be held in Canada.
- Recipient will be the top ranked researcher.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
26. Infection and Immunity (Bridge Funding) (Updated: 2010-01-26)
Summary:
- The CIHR Institute of Infection and Immunity (CIHR-III) will offer one year bridge funding for applications that are determined to be relevant to the Institute's mandate.
Funds Available:
- The total amount available for this initiative is $ 400,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to 1 year.
Additional Information:
This Priority Announcement will not require the completion of a Relevance Form.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
27. Musculoskeletal Health, Arthritis, Skin and Oral Health
Summary:
- The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA), will fund applications that are determined to be relevant to the research priority areas described below:
Funds Available:
- The total amount available for this initiative is $ 400,000. This amount may increase if additional funding partners decide to participate.
- Of this $ 400,000:
- $ 200,000 is available to fund applications relevant to new investigators
- $ 200,000 is available to fund applications relevant to non-new investigators (see below)
- The maximum amount awarded for a single grant is $ 100,000 per annum for one year.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- At least half of the grants will be allocated to new investigators (A new investigator is defined as a researcher who has completed all formal training, but with 5 years or less experience as an independent investigator. One does NOT need a new investigator salary award to be classified as a new investigator.). Any additional funding will be allocated to the next top ranked new investigator first, then the next top ranked established investigator.
- Nominated Principal Investigators are eligible to receive only one grant at a time through IMHA's priority announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from IMHA's priority announcement program, are not eligible for funding from this priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
28. Nutrition, Metabolism and Diabetes (Bridge Funding)
Summary:
- The objective of the CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) Bridging Operating Grants is to ensure the maintenance of excellent research programs aligned with the mandate of INMD.
- These operating grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.
Funds Available:
- The total amount available for this initiative is $ 100,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to 1 year.
Additional Information:
- This Priority Announcement will not require the completion of an additional Relevance Form.
- INMD must be identified as the primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Research proposals must fall within INMD's mandate.
- Nominated Principal Investigators are eligible to receive only one grant at a time through INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement.
- This Priority Announcement will apply to new grant applications as well as to renewal applications.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
29. Nutrition, Metabolism and Diabetes (INMD) (Bridge Funding for Assistant Professors, Clinicians, New Investigators)
Summary:
- This competition provides bridge grant funding to Assistant Professors, Clinicians and New Investigators working in the broad research areas of the INMD. Competition structure: 3 funding pools, to support minimum of one grant per pool:
- Assistant Professors: Assistant Professors as recognized by their host university;
- Clinician Scientist: At the time of application, a candidate must hold a professional degree and have completed at least two year of post graduate clinical training;
- New Investigators: Investigators with less than six years of experience as independent investigators since their first academic appointment.
Funds Available:
- The total amount available for this initiative is $ 300,000. This amount may increase if additional funding partners decide to participate.
- Of this $300,000:
- $100,000 is available to fund applications from New Investigators
- $100,000 is available to fund applications from Clinician Scientists
- $100,000 is available to fund applications from Assistant Professors
- The maximum amount awarded for a single grant is $ 100,000 per annum for up to 1 year.
Additional Information:
- This Priority Announcement will not require the completion of a Relevance Form.
- INMD must be identified as the primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Research proposals must fall within INMD's mandate.
- Nominated Principal Investigators are eligible to receive only one grant at a time through INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement.
- This Priority Announcement will apply to new grant applications as well as to renewal applications.
- Applicants must clearly indicate which of the 3 funding pools they are targeting. If applicable, applicants can identify up to three pools.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
Top
Eligibility
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2009-2010 funding opportunity.
Top
Guidelines
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2009-2010 funding opportunity.
Top
Performance Measurement
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2009-2010 funding opportunity.
Top
Review Process and Evaluation
A. CIHR Research Priority Areas
Relevance Review:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the Objectives section.
Prior to peer review, CIHR and the partner organizations will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application. This information will be used to review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.
Funding Decision:
Upon completion of peer review, the CIHR and the partner organizations will receive the ranking list, ratings, recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the research priority areas described under "CIHR Research Priority Areas"; and 2) (unless otherwise specified) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted.
These applications will be funded from the top down in order of ranking as far as budgets will allow.
Applications that receive a rating below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
B. Research Related to CIHR Institute Mandates
Funding Decision:
Upon completion of peer review, representatives of each CIHR Institute will receive a randomized list of applications for which the Institute was selected as primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of the ResearchNet application. The randomized list will include titles, project summaries and peer review committee recommendations on funding levels. The summaries will be used to determine the relevancy of the research to the mandate of the Institute.
Eligible applications will be funded from the top down in order of ranking as far as budgets will allow.
Applications that receive a rating below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
For Peer Review and Evlauation Criteria please refer to the Operating Grant: 2009-2010 funding opportunity.
Top
How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
- The application process for this funding opportunity is comprised of two steps: Registration and Application.
- Both Registration and Application are submitted through the "201003MOP" competition of the Operating Grant: 2009-2010 funding opportunity.
- To complete your Registration and Application, review the Operating Grant: 2009-2010 funding opportunity and then follow the specific application guidelines and instructions which are fully described in its "How to Apply" section.
- An overview of CIHR's application processes can be found under Apply for Funding.
- Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.
Submission Requirements:
A. CIHR Research Priority Areas:
- Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
- To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
- Applicants may request that their application be considered for up to three priority announcement research areas per application, in each Operating Grant competition.
B. Research Related to CIHR Institute Mandates:
- Priority announcements for research related to CIHR Institute mandates (including bridge funding priority announcements) are listed in the "Objectives" section of this funding opportunity, under "Research Related to CIHR Institute Mandates."
- When you select a CIHR Institute as a primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of your ResearchNet application, the Institute will automatically consider your application for funding through the priority announcement process whenever it offers a priority announcement for research related to its mandate. Consideration for funding through CIHR Institute mandate priority announcements is in addition to consideration for priority announcement funding in specific research priority areas.
- Applicants to the Operating Grant Program may request that their application be considered for any number of additional Priority Announcements for research related to a CIHR Institute's mandate, Linked Programs, for example, the Regional Partnerships Program, the Neuromuscular Research Program (Spring competitions only), and the CIHR-Arthritis Society Partnership Program.
Top
Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Operating Grants - Priority Announcement Program Delivery Team
Canadian Institutes of Health Research
Fax: 613-954-1800
Email: PA-AP@cihr-irsc.gc.ca
CIHR Info Desk Service
Canadian Institutes of Health Research
Telephone: 613-954-1968
Toll-free: 1-888-603-4178
Email: info@cihr-irsc.gc.ca
Specific information about the Operating Grant Program peer review committees can also be obtained by contacting the individuals listed on the CIHR Committees and Programs Contacts page of the CIHR website.
If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:
CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca
Top
Additional Information
1. Arthritis (The Arthritis Society)
- For questions about this initiative and research objectives contact:
Tanya Gallant
Program Manager/Analyst
CIHR – IMHA
Telephone: 613-954-3469
Fax: 613-954-1800
E-mail: tanya.gallant@cihr-irsc.gc.ca
Julie Wysocki
National Manager, Research and Career Development Program
The Arthritis Society
Telephone: 416-979-7228 Ext 393
E-mail: jwysocki@arthritis.ca
2. Blood Supply Risk
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager,
CIHR – ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: jennifer.ralph@cihr-irsc.gc.ca
3. Blood Utilization and Conservation
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager,
CIHR – ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: jennifer.ralph@cihr-irsc.gc.ca
4. Breast Cancer
- For questions about this initiative and research objectives contact:
Dr. Pascale Macgregor
Research Program Director
Canadian Breast Cancer Research Alliance
Telephone: 416-596-6598 ext. 360
Fax: 416-596-1714
E-mail: pmacgregor@cbcra.ca
5. Ethics
- For questions about this initiative and research objectives contact:
Lynne Cayer
Ethics Policy Advisor
CIHR Ethics Office
Telephone: 613-952-4264
Fax: 613-954-1800
E-mail: lynne.cayer@cihr-irsc.gc.ca
6. HIV/AIDS
- For questions about this initiative and research objectives contact:
Jennifer Gunning
Associate Director, HIV/AIDS Research Initiative
CIHR –Institute of Infection and Immunity
Telephone: 613-941-4483
Fax: 613-954-1800
E-mail: HIVAIDS-VIHSIDA@cihr-irsc.gc.ca.
7. Huntington's (Prize)
- For questions about this initiative and research objectives contact:
Don Lamont
Huntington Society of Canada
151 Frederick Street, Suite 400
Kitchener, Ontario N2H 2M2
Telephone: 519-749-8491 ex. 24
Email: dlamont@huntingtonsociety.ca
8. Neuromuscular Research
- For questions about this initiative and research objectives contact:
Barbara Beckett
Assistant Director, Ottawa
CIHR-INMHA
Telephone: 613-948-4877
Fax: 613-954-1800
Email: barbara.beckett@cihr-irsc.gc.ca
Elizabeth Stirling
Assistant Director, Ottawa
CIHR-IMHA
Telephone: 613-957-8678
Fax: 613-954-1800
Email: liz.stirling@cihr-irsc.gc.ca
Allison Jackson
Assistant Director, Ottawa
CIHR-IG
Telephone: 613-954-0533
Fax: 613-954-1800
Email: allison.jackson@cihr-irsc.gc.ca
Muscular Dystrophy Canada
Ursula Rehdner
Director of Research, Education and Advocacy
Suite 900-2345 Yonge Street
Toronto, ON, M4P 2E5
Telephone: 416-488-0030 ext. 134
Fax: 416-488-7523
Email: ursula.rehdner@muscle.ca
ALS Society of Canada
Denise Figlewicz
Director of Research
265 Yorkland Boulevard, Suite 300,
Toronto, Ontario, M2J 1S5
Telephone: 416-497-2267 x 202
Fax: 416-497-1256
Email: daf@als.ca
9. Obesity – Prevention and Treatment
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR – INMD
Telephone: 613-941-6465
Fax: 613-954-1800
E-mail: paul.belanger@cihr-irsc.gc.ca
10. Parkinson's Disease
- For questions about this initiative and research objectives contact:
Barbara Beckett
Assistant Director
CIHR-INMHA
Telephone: 613-948-4877
Fax: 613-954-1800
Email: barbara.beckett@cihr-irsc.gc.ca
11. Regional Partnerships Program – Manitoba
- For additional information on eligibility criteria and funding details, please contact:
Shannon Rogalski
Manager, Funding Programs
Manitoba Health Research Council
Phone: 204-783-4249
Email: shannon.rogalski@mhrc.mb.ca
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
12. Regional Partnerships Program – New Brunswick
- For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne
Administrator
Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB, E3B 5G8
Telephone: 506-444-3222
Fax: 506-453-2958
Email: john.boyne@gnb.ca
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
13. Regional Partnerships Program – Newfoundland and Labrador
- For additional information on eligibility criteria and funding details, please contact:
Office of Research and Graduate Studies
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL, A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
14. Regional Partnerships Program – Nova Scotia
- Contact for this program is:
Jennifer McNutt
Manager, Health Research & Matching Grants Programs
Nova Scotia Health Research Foundation
Telephone: 902-424-3370
Fax: 902-424-7753
E-mail: jennifer.mcnutt@gov.ns.ca
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
15. Regional Partnerships Program – Prince Edward Island
- Please contact the following for additional information:
Leslie Cudmore
University of Prince Edward Island
Office of Research & Development
550 University Avenue
Charlottetown, PE, C1A 4P3
Telephone: 902-566-0709
Fax: 902-620-5092
Email: lcudmore@upei.ca
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
16. Regional Partnerships Program – Saskatchewan
- Please contact the Research Offices at the University of Saskatchewan and the University of Regina for more information:
Research Services
University of Saskatchewan
Box 5000 RPO University
Saskatoon, SK, S7N 4J8
Telephone: 306-966-8576
Fax: 306-966-8597
E-mail: research.services@usask.ca
Office of Research Services
University of Regina
3737 Wascana Parkway
Regina, SK, S4S 0A2
Telephone: 306-585-4775
Fax: 306-585-4893
E-mail: research.services@uregina.ca
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
17. Reproductive and Child Health (Start Up Grants)
- For questions about this initiative and research objectives contact:
Anne-Cécile Desfaits, PhD (Updated: 2010-01-13)
Assistant Director
CIHR-IHDCYH
Telephone: 514-412-4414
Fax: 514-412-4253
Email: anne-cecile.desfaits@cihr-irsc.gc.ca
18. Schizophrenia (Prize)
- For questions about this initiative and research objectives contact:
John E. Gray, PhD
Chair
Schizophrenia Society of Canada
4 Fort Street,
Winnipeg, MB R3C1C4
Tel: (204) 786-1616
Cell: (204) 223-9158
Fax: (204) 783-4898
Email: jegray@shaw.ca
19. Spinal Cord Research
- For questions about this initiative and research objectives contact:
Barbara Beckett, Assistant Director, CIHR-INMHA
Telephone: 613-948-4877
Fax: 613-954-1800
Email: bbeckett@cihr-irsc.gc.ca
20. Transfusion Related Acute Lung Injury (TRALI)
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager,
CIHR – ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: jennifer.ralph@cihr-irsc.gc.ca
21. Cancer Research (Bridge Funding)
- For questions about this initiative and research objectives contact:
Benoît Lussier, Ph.D.
Assistant Director
CIHR – Institute of Cancer Research
Telephone: 514-398-4964
Fax: 514-398-8845
E-mail: benoit.lussier@mcgill.ca
22. Circulatory and Respiratory Health (Bridge Funding)
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager,
CIHR – ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: jennifer.ralph@cihr-irsc.gc.ca
23. First Nations, Inuit and/or Métis Health
- For questions about this initiative and research objectives contact:
Sonia Cayer, Team Lead, CIHR
Telephone: 613- 954-6054
Fax: 613-954-1800
E-mail: sonia.cayer@cihr-irsc.gc.ca
Jacques Dalton, Project Officer, CIHR – IAPH
Telephone: 613-941-4440
Fax: 613-954-1800
E-mail: jacques.dalton@cihr-irsc.gc.ca
24.Genetics (Bridge Funding)
- For questions about this initiative and research objectives contact:
Jennifer Ahlgren
Institute Project Officer
CIHR – Institute of Genetics
Telephone: 613-957-6126
Fax: 613-954-1800
E-mail: jennifer.ahlgren@cihr-irsc.gc.ca
25. Genetics - Maud Menten New Principal Investigator Prizes (2010)
- For questions about this initiative and research objectives contact:
Jennifer Ahlgren
Institute Project Officer
CIHR – Institute of Genetics
Telephone: 613-957-6126
Fax: 613-954-1800
E-mail: jennifer.ahlgren@cihr-irsc.gc.ca
26. Infection and Immunity (Bridge Funding) (Updated: 2010-01-26)
- For questions about this initiative and research objectives contact:
Christian Brochu
Associate, Strategic Initiatives
CIHR – III
Telephone: 613-941-4329
Fax: 613-954-1800
E-mail: christian.brochu@cihr-irsc.gc.ca
27. Musculoskeletal Health, Arthritis, Skin and Oral Health
- For questions about this initiative and research objectives contact:
Tanya Gallant
Program Manager/Analyst
CIHR – IMHA
Telephone: 613-954-3469
Fax: 613-954-1800
E-mail: Tanya.gallant@cihr-irsc.gc.ca
28. Nutrition, Metabolism and Diabetes (Bridge Funding)
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR – INMD
Telephone: 613-941-6465
Fax: 613-954-1800
E-mail: paul.belanger@cihr-irsc.gc.ca
29. Nutrition, Metabolism and Diabetes (Bridge Funding for Assistant Professors, Clinicians, New Investigators)
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR – INMD
Telephone: 613-941-6465
Fax: 613-954-1800
E-mail: paul.belanger@cihr-irsc.gc.ca
Top
|
